These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 15297062

  • 1. Full-length HIV-1 Tat protein necessary for a vaccine.
    Opi S, Péloponèse JM, Esquieu D, Watkins J, Campbell G, De Mareuil J, Jeang KT, Yirrell DL, Kaleebu P, Loret EP.
    Vaccine; 2004 Aug 13; 22(23-24):3105-11. PubMed ID: 15297062
    [Abstract] [Full Text] [Related]

  • 2. Sequence conservation and antibody cross-recognition of clade B human immunodeficiency virus (HIV) type 1 Tat protein in HIV-1-infected Italians, Ugandans, and South Africans.
    Buttò S, Fiorelli V, Tripiciano A, Ruiz-Alvarez MJ, Scoglio A, Ensoli F, Ciccozzi M, Collacchi B, Sabbatucci M, Cafaro A, Guzmán CA, Borsetti A, Caputo A, Vardas E, Colvin M, Lukwiya M, Rezza G, Ensoli B, Tat Multicentric Study Group.
    J Infect Dis; 2003 Oct 15; 188(8):1171-80. PubMed ID: 14551888
    [Abstract] [Full Text] [Related]

  • 3. Tat HIV-1 primary and tertiary structures critical to immune response against non-homologous variants.
    Opi S, Péloponèse JM, Esquieu D, Campbell G, de Mareuil J, Walburger A, Solomiac M, Grégoire C, Bouveret E, Yirrell DL, Loret EP.
    J Biol Chem; 2002 Sep 27; 277(39):35915-9. PubMed ID: 12080071
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Cynomolgus macaques immunized with two HIV-1 Tat stabilized proteins raise strong and long-lasting immune responses with a pattern of Th1/Th2 response differing from that in mice.
    Turbant S, Martinon F, Moine G, Le Grand R, Léonetti M.
    Vaccine; 2009 Aug 27; 27(39):5349-56. PubMed ID: 19607953
    [Abstract] [Full Text] [Related]

  • 11. A synthetic HIV-1 Tat protein breaches the skin barrier and elicits Tat-neutralizing antibodies and cellular immunity.
    Partidos CD, Moreau E, Chaloin O, Tunis M, Briand JP, Desgranges C, Muller S.
    Eur J Immunol; 2004 Dec 27; 34(12):3723-31. PubMed ID: 15549730
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Tat toxoid: its potential role as an HIV vaccine.
    Lambert J.
    J Hum Virol; 1998 Dec 27; 1(4):249-50. PubMed ID: 10195248
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins.
    Desfosses Y, Solis M, Sun Q, Grandvaux N, Van Lint C, Burny A, Gatignol A, Wainberg MA, Lin R, Hiscott J.
    J Virol; 2005 Jul 27; 79(14):9180-91. PubMed ID: 15994812
    [Abstract] [Full Text] [Related]

  • 16. Plant based HIV-1 vaccine candidate: Tat protein produced in spinach.
    Karasev AV, Foulke S, Wellens C, Rich A, Shon KJ, Zwierzynski I, Hone D, Koprowski H, Reitz M.
    Vaccine; 2005 Mar 07; 23(15):1875-80. PubMed ID: 15734059
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.